← Back to Search

Behavioural Intervention

Signos System for Obesity (SWEET Trial)

N/A
Waitlist Available
Research Sponsored by Signos Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be at least 22 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

SWEET Trial Summary

This trial aims to study how continuous glucose monitoring (CGM) and mobile health (mHealth) platforms can help people without diabetes improve their health by achieving weight loss goals. The researchers believe that using

Who is the study for?
This trial is for adults who are dealing with obesity or metabolic syndrome and want to manage their weight. Participants should be interested in using a mobile health platform (Signos System) alongside standard lifestyle education to achieve their weight goals.Check my eligibility
What is being tested?
The study tests whether the Signos mHealth Platform, which includes continuous glucose monitoring and personalized coaching, can help people lose weight more effectively than just getting standard lifestyle advice.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like diet and exercise guidance through an app, side effects may include typical responses to dietary changes or increased physical activity.

SWEET Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 22 years old.

SWEET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average Total Body Weight Loss (TBWL%)
Responder Rate

SWEET Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Signos SystemExperimental Treatment1 Intervention
For all consented participants, the Signos app will use CGM data to provide recommendations customized to users for promoting general health and wellness.
Group II: Standard Lifestyle EducationActive Control1 Intervention
The "Active Comparator: Standard Lifestyle Education" arm in the clinical trial refers to a control group that receives conventional lifestyle modification advice instead of the experimental Signos System.

Find a Location

Who is running the clinical trial?

Signos IncLead Sponsor
2 Previous Clinical Trials
70,000 Total Patients Enrolled
Lindus Health, Inc.UNKNOWN
Stephanie Kim, MDStudy ChairSignos Inc
1 Previous Clinical Trials
20,000 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

At present, how many distinct locations are simultaneously conducting this experimental investigation?

"Patients are welcome to participate in this clinical trial at Diablo Clinical Research, located in Walnut Creek, California. Additionally, Helios Clinical Research in Phoenix, Arizona and Segal Trials situated in North Miami, Florida are also open for patient enrollment. Furthermore, there are five additional locations available for participation as well."

Answered by AI

Are there any available openings for patients to participate in this study?

"Indeed. As per the details available on clinicaltrials.gov, this trial is currently seeking eligible candidates. The initial posting date for this study was January 2nd, 2024, and it underwent its most recent update on January 9th, 2024."

Answered by AI

What is the current number of individuals being recruited for participation in this research study?

"To successfully carry out this clinical trial, a total of 380 eligible participants are needed. The study will be conducted by the sponsor, Signos Inc., at multiple sites including Diablo Clinical Research located in Walnut Creek, California and Helios Clinical Research (Phoenix) based in Phoenix, Arizona."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Met criteria
What site did they apply to?
Helios Clinical Research
Seattle Clinical Research
Helios Clinical Research (Phoenix)

Why did patients apply to this trial?

I was.on mourjaro for 8 months it works fabulous! My Insurance is not covering it now because I do not have diabetes .
PatientReceived no prior treatments
Recent research and studies
PLOS BiologyJournal
Glucotypes Reveal New Patterns of Glucose Dysregulation
Hall, Heather, Dalia Perelman, Alessandra Breschi, Patricia Limcaoco, Ryan Kellogg, Tracey McLaughlin, and Michael Snyder. 2018. “Glucotypes Reveal New Patterns of Glucose Dysregulation”. Edited by Jason Locasale. PLOS Biology. Public Library of Science (PLoS). doi:10.1371/journal.pbio.2005143.
Diabetes, Metabolic Syndrome and Obesity: Targets and TherapyJournal
The Impact of Brief High-intensity Exercise on Blood Glucose Levels
Adams, Peter. 2013. “The Impact of Brief High-intensity Exercise on Blood Glucose Levels”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. Informa UK Limited. doi:10.2147/dmso.s29222.
DiabetologiaJournal
Mechanisms of Hyperinsulinaemia in Apparently Healthy Non-obese Young Adults: Role of Insulin Secretion, Clearance and Action and Associations with Plasma Amino Acids
Hamley, Steven, Danielle Kloosterman, Tamara Duthie, Chiara Dalla Man, Roberto Visentin, Shaun A. Mason, Teddy Ang, et al.. 2019. “Mechanisms of Hyperinsulinaemia in Apparently Healthy Non-obese Young Adults: Role of Insulin Secretion, Clearance and Action and Associations with Plasma Amino Acids”. Diabetologia. Springer Science and Business Media LLC. doi:10.1007/s00125-019-04990-y.
Scientific ReportsJournal
Successful Weight Reduction and Maintenance by Using a Smartphone Application in Those with Overweight and Obesity
Chin, Sang Ouk, Changwon Keum, Junghoon Woo, Jehwan Park, Hyung Jin Choi, Jeong-taek Woo, and Sang Youl Rhee. 2016. “Successful Weight Reduction and Maintenance by Using a Smartphone Application in Those with Overweight and Obesity”. Scientific Reports. Springer Science and Business Media LLC. doi:10.1038/srep34563.
All > Weight Loss Glendale > Paid Studies Pasadena
~253 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top